Montefiore Medical Center first to perform minimally invasive procedure on uterine fibroids

NewsGuard 100/100 Score

Montefiore Medical Center recently became the only hospital on the East Coast to conduct the Radio Frequency Ablation procedure to shrink uterine fibroids in women 30 years and older. This minimally invasive procedure, initially used to treat liver cancer, uses a tiny needle that is inserted into the fibroid, applying low energy radio frequency electrical current, which creates localized tumor destruction by heat.

"More than 30% of all women suffer from fibroids, which can cause excessive menstrual bleeding and pain," said Erika Banks, MD, Director of the Fibroid Center at Montefiore and lead investigator of the study. "This procedure is another option for these women who wish to preserve their uterus -- an important advantage of this minimally invasive procedure."

Fibroids are benign tumors, which grow in the uterus. Fibroids are the most common tumor in the reproductive years, and are 2-3 times more common among African American women. Symptoms include heavy and or painful menstrual bleeding, a feeling of pressure in the pelvis, frequent urination, pain during intercourse, abdominal bloating and abdominal pain and/or back ache.

Montefiore is one of only five medical centers in the U.S. to test this procedure. The other centers are in California, Arizona, Michigan and Missouri. This study is currently enrolling women with fibroids and heavy bleeding who no longer desire fertility.

Treatment of 235 fibroid tumors in 70 women outside the U.S. resulted in significant reduction of symptoms and improvement in quality of life for about 90% of women, according to Dr. Banks.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer